C. Ronet

Discipline

Sociologie (1) Anthropologie biologique (1)

Type de document

Articles (21) Recensions (3)

Co-auteur

Date

Source

Mot-clé

Leishmania (18) Infection (15) infection (14) Leishmaniasis (14) virus (12) Mice (12) parasite (11) maladie (11) Parasites (11) Parasites (11) maladie (11) RNA (10) Human beings (9) Treatment (8) Animals (8) Infections (8) Development (7) T cells (7) Immune response (7) Cells (7) espèce (6) Double-stranded RNA (6) Species (6) Control (5) Patients (5) Macrophages (5) Expression (5) Patients (5) résistance (5) thérapie (4)

Documents écrit par C. Ronet (21) | parle de C. Ronet (0)

Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy.
F.G. Herrera et al.
Cell-autonomous inflammation of BRCA1-deficient ovarian cancers drives both tumor-intrinsic immunoreactivity and immune resistance via STING.
M. Bruand et al. (20 juil. 2021)
Optimized gene engineering of murine CAR-T cells reveals the beneficial effects of IL-15 coexpression.
E. Lanitis et al. (1 févr. 2021)
Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis.
M. Rossi et al. (9 mai 2017)
Exacerbated Leishmaniasis Caused by a Viral Endosymbiont can be Prevented by Immunization with Its Viral Capsid.
P. Castiglioni et al. (2017)
Tilting the balance between RNA interference and replication eradicates Leishmania RNA virus 1 and mitigates the inflammatory response.
E.A. Brettmann et al. (25 oct. 2016)
Mammalian Innate Immune Response to a Leishmania-Resident RNA Virus Increases Macrophage Survival to Promote Parasite Persistence.
R.O. Eren et al. (14 sept. 2016)
Severe Cutaneous Leishmaniasis in a Human Immunodeficiency Virus Patient Coinfected with Leishmania braziliensis and Its Endosymbiotic Virus.
L. Parmentier et al. (2016)
Leishmaniavirus-Dependent Metastatic Leishmaniasis Is Prevented by Blocking IL-17A.
M.A. Hartley et al. (2016)
Leishmania aethiopica field isolates bearing an endosymbiontic dsRNA virus induce pro-inflammatory cytokine response.
H. Zangger et al. (2014)
The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis.
M.A. Hartley et al. (2014)
MyD88 and TLR9 dependent immune responses mediate resistance to Leishmania guyanensis infections, irrespective of Leishmania RNA virus burden.
A. Ives et al. (2014)
A scoring method to standardize lesion monitoring following intra-dermal infection of Leishmania parasites in the murine ear
S. Schuster et al. (2014)
Detection of Leishmania RNA virus in Leishmania parasites.
H. Zangger et al. (2013)
Leishmania RNA virus: when the host pays the toll.
M.A. Hartley et al. (2012)
Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis.
A. Ives et al. (2011)
Un virus, hôte indésirable de L. guyanensis, détermine la gravité de la forme mucocutanée de la leishmaniose [Mucocutaneous leishmaniasis and an undesired passenger].
C. Ronet et al. (2011)
Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production.
C. Ronet et al. (2010)
In leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment.
E. Bourreau et al. (2009)
Leishmania major-specific B cells are necessary for Th2 cell development and susceptibility to L. major LV39 in BALB/c mice.
C. Ronet et al. (2008)
Selective expression of the V beta 14 T cell receptor on Leishmania guyanensis--specific CD8+ T cells during human infection.
A. Kariminia et al. (2007)